DIRS.INFO The most relevant business & tech news

☆ New U.S. cancer drug prices rise 53% in five years -report
▼ + stars: | 2022-11-02 | by ( Deena Beasley | ) www.reuters.com time to read: +4 min

"I do think there is a possibility we see launch prices go up," she said. Reuters GraphicsPorter, who championed inflation-based caps on drug prices, is calling for additional national legislation to link launch prices to how well a drug works. The report found that the average launch price of a self-administered cancer drug, after adjusting for inflation, rose by nearly 26% to $238,000 between 2017 and 2021. By 2022, six out of the eight newly-launched oral cancer drugs had prices over $200,000 per year. Based on current trends, the report calculated that by 2026, when Medicare will first be able to negotiate drug prices, the average self-administered cancer drug launch price will be nearly $325,000 per year and over $525,000 for pills and biologics.

☆ Premarket stocks: Why America's job market hasn't imploded
▼ + stars: | 2022-11-01 | by ( Nicole Goodkind | ) edition.cnn.com time to read: +6 min

Mortgage rates are at their highest levels since 2002, consumer spending and business investment is falling and the Federal Reserve is fighting persistent inflation with higher interest rates. “While job openings should continue to fall in the months ahead, the fact that they remain well above normal levels should continue to support strong job growth, possibly all the way into 2023,” said David Kelly, chief global strategist at JPMorgan Funds. The job market is good for workers but it’s not good for inflation. The problem is that this time around, the shape of the job market is different. Oil stocks and health care companies are leading the market, with Chevron (CVX), Merck (MRK) and Amgen (AMGN) topping the Dow leaders list.

☆ Sell biopharma stock Amgen ahead of its obesity drug update, Barclays says
▼ + stars: | 2022-10-31 | by ( Sarah Min | ) www.cnbc.com time to read: +2 min

Investors should sell biopharma stock Amgen ahead of its obesity drug update next week, according to Barclays. Analyst Carter Gould downgraded Amgen to underweight from equal weight, saying there are high expectations around its obesity drug AMG133 after the stock's rally this month. Amgen shares outperformed nearly all its peers this month, even companies that have reported strong third-quarter results, after announcing at the start of October that it will disclose more obesity drug data, according to Barclays. In short, we think AMGN shares could come under pressure after the recent gains on the back of this update," the analyst wrote. The analyst's $234 price target represents 14.5% downside from where Amgen shares closed Friday at $273.81.

☆ Stocks: Dow on track for best month in more than 45 years
▼ + stars: | 2022-10-31 | by ( Paul R. La Monica | ) edition.cnn.com time to read: +3 min

New York CNN Business —The Dow fell slightly midday Monday but is still up 14% this month, putting it on track for its best monthly gain since January 1976. Still, it’s fitting that on Halloween, candy maker Hershey (HSY) is trading at an all-time high, Shares are up nearly 25% this year. That’s nearly half of the Dow stocks. Oil stocks and health care companies are leading the market, with Chevron (CVX), Merck (MRK) and Amgen (AMGN) topping the Dow leaders list. This list of well known, brand-name stocks trading at record highs is further proof of that point.

☆ What Cramer is watching Monday — October's stock pop, tech reign over, China's zero Covid
▼ + stars: | 2022-10-31 | by ( Jim Cramer | ) www.cnbc.com time to read: +5 min

Club holding Wynn Resorts (WYNN) jumps 5% in the premarket after a 4.5% pop Friday. UBS downgrades Caterpillar (CAT) to neutral (hold) from buy; cuts price target by $5-per-share to $230, which is silly. Outback Steakhouse owner Bloomin' Brands (BLMN): two price target boosts, Citi and Barclays. Barclays: LyondellBasell (LYB) downgraded to equal weight from overweight (hold from buy), cut price target to $82 per share from $95. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.

☆ Here are Monday's biggest analyst calls: Tesla, Apple, Southwest, Uber, Roku, Home Depot, AMD & more
▼ + stars: | 2022-10-31 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

UBS downgrades Caterpillar to neutral from buy UBS said in its downgrade of Caterpillar that it sees a more "balanced risk/reward." Morgan Stanley upgrades Pure Storage to overweight from equal weight Morgan Stanley said in its upgrade of the data flash storage company that it sees "share gains and growing value proposition." Morgan Stanley reiterates Southwest as a top pick Morgan Stanley says it has "solid confidence" in shares of Southwest. Morgan Stanley reiterates Charles Schwab as a top pick Morgan Stanley says it's standing by the stock despite shares underperforming. Oppenheimer reiterates Uber as outperform Oppenheimer says Uber shares have a "compelling value proposition" ahead of earnings on Tuesday.

☆ The Fed may have to blow up the economy to get inflation under control
▼ + stars: | 2022-10-30 | by ( Paul R. La Monica | ) edition.cnn.com time to read: +7 min

Jobs report also on tapThe Fed meeting takes place just two days before the nation will get its next report card on the labor market. Another jobs report, from payroll processor ADP, is also due out next week, and this one looks just at Corporate America. The government said in the September jobs report that average hourly earnings rose 5% in the past 12 months. The Fed typically prefers to see wage growth in the 2% to 3% annual range as a sign that inflation is under control. Discovery, Starbucks (SBUX), PayPal (PYPL), Amgen (AMGN) and Block (SQ)Friday: US jobs report; earnings from Cardinal Health (CAH), Duke Energy (DUK) and Hershey (HSY)

☆ Stocks shrug off tech's troubles as the Street awaits key inflation data next week
▼ + stars: | 2022-10-28 | by ( Zev Fima | ) www.cnbc.com time to read: +9 min

The major indexes all posted gains this week despite a Big Tech beatdown, proving the market can rally without its most valuable stocks. Indeed strength in other sectors — only communication services finished down — helped the overall market to shrug off disappointing earnings results from Microsoft (MSFT), Alphabet (GOOGL), Amazon (AMZN) and Meta Platforms (META). Alphabet's results fell short of the Street's expectations, but still managed to grow revenue 6% annually off a $65 billion base. (Canada's central bank hiked rates less than expected this week, opting for a 50 basis point hike instead of the expected 75.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.

☆ Cramer: This bear market is getting long in the tooth — here's what is changing
▼ + stars: | 2022-10-23 | by ( Jim Cramer | ) www.cnbc.com time to read: +8 min

Owning a Johnson & Johnson (JNJ) or a Constellation Brands (STZ) isn't exciting. When I look at the companies that have reported already, I like Home Depot (HD) and UnitedHealth (UNH), Procter & Gamble (PG) and Johnson & Johnson. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

☆ A portfolio manager beating 99% of his peers this year breaks down why the market has another 15% to 20% of downside ahead — and shares the biggest mistake investors could make once the Fed begins to
▼ + stars: | 2022-10-17 | by ( Lisa Kailai Han | ) www.businessinsider.com time to read: +7 min

Drawing from the dot-com crash, he believes the current bear market still has 15%-20% more downside. Abate also shared the biggest mistake investors could make once the Fed begins to ease once more. Today's bear market mirrors the dot-com crashPart of Abate's investment process involves drawing parallels between the current market and historical recessions. "I still think that we are in the midst of a bear market. Similarly, both bear markets were also kicked off by an "excessive period of poor allocation of investment capital," Abate said.

☆ 9 Stock Picks, Investing Strategy From Top 1% Fund Manager in 2022
▼ + stars: | 2022-10-14 | by ( Lisa Kailai Han | ) www.businessinsider.com time to read: +7 min

James Abate's fund has beaten 99% of its peers this year and over one, three, and five years. Here are his 9 standout stock picks which he says have enough pricing power to beat the bear market. He compared this dogmatic style of investing — purposely ignoring opportunities in the market — to horses running around a track with blinders on. Within energy, Abate specifically likes more gas-related names versus oil-related ones, with two standouts including Exxon Mobil (XOM) and EQT (EQT). Below is the full list of Abate's nine standout stocks along with the ticker, market capitalization, and sector for each.

☆ S&P 500, Nasdaq end lower; BoE comments add to market jitters late
▼ + stars: | 2022-10-11 | by ( Caroline Valetkevitch | ) www.reuters.com time to read: +3 min

Trading was volatile, with investors cautious ahead of key U.S. inflation data and the start of third-quarter earnings later this week. The S&P banks index (.SPXBK) was down 2.6% ahead of quarterly results from some major banks later this week. The reports are expected to kick off the third quarter reporting period for S&P 500 companies. read moreDeclining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.51-to-1 ratio favored decliners. The S&P 500 posted one new 52-week high and 104 new lows; the Nasdaq Composite recorded 33 new highs and 590 new lows.

☆ Dow, S&P 500 rise after recent losses; investors prepare for inflation, earnings data
▼ + stars: | 2022-10-11 | by ( Caroline Valetkevitch | ) www.reuters.com time to read: +3 min

Register now for FREE unlimited access to Reuters.com RegisterInvestors were anxiously awaiting the producer price index report Wednesday and consumer price index data on Thursday. "A few investors might be trying to bet on a better-than-expected inflation report," said Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago. The S&P bank index (.SPXBK) was down 1.1% ahead of quarterly results from some major banks later this week. The reports are expected to kick off the third-quarter reporting period for S&P 500 companies. The S&P 500 posted one new 52-week high and 95 new lows; the Nasdaq Composite recorded 19 new highs and 517 new lows.

☆ S&P 500, Nasdaq fall on fears of profit hit from inflation, rate hikes
▼ + stars: | 2022-10-11 | by ( Shreyashi Sanyal | ) www.reuters.com time to read: +4 min

With recent jobs and inflation data suggesting more big interest rate hikes by the Federal Reserve, Wall Street's main indexes have been clocking losses in the past few sessions on fears of the economy slipping into a recession. Register now for FREE unlimited access to Reuters.com Register"The market wants to see data, show me the numbers, show me we're getting inflation down. 1/4 A trader works on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., October 11, 2022. The CBOE Volatility index (.VIX), rose for a fourth straight session, inching closer to near two-weeks high. The S&P index recorded one new 52-week high and 95 new lows, while the Nasdaq recorded 15 new highs and 492 new lows.

☆ Wall St falls on worries of lower third-quarter corporate profit; Amgen jumps
▼ + stars: | 2022-10-11 | by ( Shreyashi Sanyal | ) www.reuters.com time to read: +4 min

Big U.S. banks are set to report quarterly results on Friday that may offer insight into the health of the U.S. economy. "Right now the market wants to see data, show me the numbers, show me we're getting inflation down. Until then, this market is probably stuck in this whole death by a 1,000 cuts scenario," Dick said. Declining issues outnumbered advancers for a 3.28-to-1 ratio on the NYSE and for a 2.36-to-1 ratio on the Nasdaq. The S&P index recorded no new 52-week high and 71 new lows, while the Nasdaq recorded 10 new highs and 250 new lows.

The three main indexes have been on a loss-making streak in the past few sessions as recent data continues to point to more policy tightening by the U.S. Federal Reserve that could tip the economy into a recession. With recent economic indicators signaling persistent inflation going forward, money markets are pricing in a 92% chance of another 75-basis-point hike at the Fed's meeting in November. read moreMajor U.S. banks are set to report third-quarter results on Friday that may offer insight into the health of the U.S. economy. ET, Dow e-minis were up 6 points, or 0.02%, S&P 500 e-minis were down 2.25 points, or 0.06%, and Nasdaq 100 e-minis were down 10.25 points, or 0.09%. Amgen Inc (AMGN.O) shares jumped nearly 3% after a report said Morgan Stanley upgraded the drugmaker's stock to "overweight" from "equal weight".

☆ A fund manager who's beaten 97% of his peers over the last 3 years shares 8 stocks he's betting on for the next 3-5 years — and breaks down the key tenets of his investing philosophy
▼ + stars: | 2022-09-21 | by ( William Edwards | ) www.businessinsider.com time to read: +4 min

Quality stocks are those that generate robust and stable profits, and have high returns on equity. In addition to having robust profit margins, Stimpson also likes firms that show strong earnings growth. 8 stocks Stimpson is betting onTwo sectors in the market with a growth tilt are technology and healthcare. He also likes semiconductor firms because he thinks they're oversold and undervalued. Four semiconductor firms he likes include: Cirrus Logic (CRUS), Ambarella (AMBA), KLA-Tencor (KLA), and Kulicke & Soffa Industries (KLIC).

☆ 3 of our stocks are in the news — here's our take on what's happening
▼ + stars: | 2022-09-21 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +10 min

Scharf, who took over the troubled lender in October 2019, said in his congressional testimony Wednesday that Wells Fargo has "approximately $1.9 trillion in assets." The Club take: Our investment thesis in Wells Fargo largely rests on a two-pronged approach to boost earnings. As rates rise, Wells Fargo can make more money on the spread between what it pays customers for deposits and what it charges for loans. Still, intensifying recession fears have ultimately been a drag on Wells Fargo shares this year. Investors must be realists, though, and our stake in Wells Fargo never assumed it would be a quick fix.

Search resuls for: "AMGN"

18 mentions found